| Amanda N Hill, FNP-BC | |
|
800 Oak Ridge Turnpike C-200, Oak Ridge, TN 37830 | |
| (865) 483-3594 | |
| (865) 483-4910 |
| Full Name | Amanda N Hill |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 800 Oak Ridge Turnpike C-200, Oak Ridge, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114440856 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 22744 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cumberland Medical Center | Crossville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Medicine Services Of Tennessee Pc | 9234432881 | 140 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
Hamilton Thorne Ltd., formerly Calotto Capital Inc., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today reported operational and financial results for the third quarter ended September 30, 2009
Argos Therapeutics today announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden.
PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate cancer, according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
ISTA Pharmaceuticals, Inc. today highlighted results from the Company's REMURA (bromfenac ophthalmic solution for dry eye) Phase 2 clinical study.
› Verified 2 days ago
| Entity Name | East Tennessee Pulmonary Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992717599 PECOS PAC ID: 0446208185 Enrollment ID: O20050110000136 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
Hamilton Thorne Ltd., formerly Calotto Capital Inc., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today reported operational and financial results for the third quarter ended September 30, 2009
Argos Therapeutics today announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden.
PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate cancer, according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
ISTA Pharmaceuticals, Inc. today highlighted results from the Company's REMURA (bromfenac ophthalmic solution for dry eye) Phase 2 clinical study.
› Verified 2 days ago
| Entity Name | Eric Hasemeier Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225141492 PECOS PAC ID: 4789687484 Enrollment ID: O20060818000335 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
Hamilton Thorne Ltd., formerly Calotto Capital Inc., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today reported operational and financial results for the third quarter ended September 30, 2009
Argos Therapeutics today announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden.
PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate cancer, according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
ISTA Pharmaceuticals, Inc. today highlighted results from the Company's REMURA (bromfenac ophthalmic solution for dry eye) Phase 2 clinical study.
› Verified 2 days ago
| Entity Name | Hospital Medicine Services Of Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528433802 PECOS PAC ID: 9234432881 Enrollment ID: O20160114002673 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
Hamilton Thorne Ltd., formerly Calotto Capital Inc., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today reported operational and financial results for the third quarter ended September 30, 2009
Argos Therapeutics today announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden.
PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate cancer, according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
ISTA Pharmaceuticals, Inc. today highlighted results from the Company's REMURA (bromfenac ophthalmic solution for dry eye) Phase 2 clinical study.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda N Hill, FNP-BC 800 Oak Ridge Turnpike C-200, Oak Ridge, TN 37830 Ph: (865) 483-3594 | Amanda N Hill, FNP-BC 800 Oak Ridge Turnpike C-200, Oak Ridge, TN 37830 Ph: (865) 483-3594 |
News Archive
As the United States continues to experience a nursing shortage that is expected to grow to one million nurses by 2016, a new research study highlights a pool of potential candidates who could alleviate the shortage in an economical way.
Hamilton Thorne Ltd., formerly Calotto Capital Inc., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today reported operational and financial results for the third quarter ended September 30, 2009
Argos Therapeutics today announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden.
PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate cancer, according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
ISTA Pharmaceuticals, Inc. today highlighted results from the Company's REMURA (bromfenac ophthalmic solution for dry eye) Phase 2 clinical study.
› Verified 2 days ago
Mrs. Jessica Lynn Hamby, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 80 Vermont Ave, Oak Ridge, TN 37830 Phone: 865-482-4078 | |
Kimberly R Smith, MSN, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 221 W Tyrone Rd, Oak Ridge, TN 37830 Phone: 865-483-6343 Fax: 865-483-1185 | |
Jean F. Marler, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 988 Oak Ridge Tpke, Suite 140 Physicians Plaza, Oak Ridge, TN 37830 Phone: 865-483-7415 Fax: 865-483-7980 | |
Laura A Cutler, ANP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 80 Vermont Ave, Oak Ridge, TN 37830 Phone: 865-482-4078 Fax: 865-482-4960 | |
Mrs. Jocelyn Rebeccah Chermak, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 New York Ave Ste 200, Oak Ridge, TN 37830 Phone: 865-835-5400 | |
Patricia J Myers, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 801 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-483-3172 | |
Victoria L Cooper, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 801 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-483-3172 Fax: 833-908-2163 |